Outcomes	O
assessment	O
:	O
The	O
primary	O
outcomes	O
included	O
virological	O
and	O
clinical	O
evaluations	O
.	O

Time	B-PrimaryOutcome
to	I-PrimaryOutcome
SARS	I-PrimaryOutcome
-	I-PrimaryOutcome
CoV	I-PrimaryOutcome
-	I-PrimaryOutcome
2	I-PrimaryOutcome
RNA	I-PrimaryOutcome
negativization	I-PrimaryOutcome
(	B-OutcomeDefinition
absence	I-OutcomeDefinition
of	I-OutcomeDefinition
the	I-OutcomeDefinition
virus	I-OutcomeDefinition
according	I-OutcomeDefinition
to	I-OutcomeDefinition
the	I-OutcomeDefinition
RT	I-OutcomeDefinition
-	I-OutcomeDefinition
PCR	I-OutcomeDefinition
)	O
in	O
positive	O
patients	O
after	O
starting	O
antiviral	O
therapy	O
was	O
the	O
virological	O
endpoint	O
.	O

It	O
was	O
expressed	O
as	O
the	O
percentage	B-OutcomeDefinition
of	I-OutcomeDefinition
patients	I-OutcomeDefinition
negative	I-OutcomeDefinition
to	I-OutcomeDefinition
SARS	I-OutcomeDefinition
-	I-OutcomeDefinition
CoV	I-OutcomeDefinition
-	I-OutcomeDefinition
2	I-OutcomeDefinition
by	I-OutcomeDefinition
RT	I-OutcomeDefinition
-	I-OutcomeDefinition
PCR	I-OutcomeDefinition
in	I-OutcomeDefinition
throat	I-OutcomeDefinition
exudate	I-OutcomeDefinition
tissue	I-OutcomeDefinition
calculated	O
at	B-TimeFrame
48	I-TimeFrame
,	I-TimeFrame
72	I-TimeFrame
,	I-TimeFrame
96	I-TimeFrame
and	I-TimeFrame
120	I-TimeFrame
hours	I-TimeFrame
.	O

Days	O
to	O
reach	O
the	O
viral	O
negativization	O
were	O
analyzed	O
by	O
Kaplan	O
-	O
Meier	O
plots	O
and	O
compared	O
with	O
a	O
Log	O
-	O
rank	O
test	O
.	O

Hazard	O
Ratio	O
with	O
95	O
%	O
CI	O
of	O
ratio	O
was	O
also	O
calculated	O
.	O

The	O
clinical	B-PrimaryOutcome
evaluation	I-PrimaryOutcome
considered	O
the	O
time	B-OutcomeDefinition
to	I-OutcomeDefinition
progression	I-OutcomeDefinition
to	I-OutcomeDefinition
severe	I-OutcomeDefinition
COVID	I-OutcomeDefinition
-	I-OutcomeDefinition
19	I-OutcomeDefinition
and	O
it	O
was	O
calculated	O
by	O
the	O
percentage	B-OutcomeDefinition
of	I-OutcomeDefinition
patients	I-OutcomeDefinition
who	I-OutcomeDefinition
became	I-OutcomeDefinition
severely	I-OutcomeDefinition
ill	I-OutcomeDefinition
after	I-OutcomeDefinition
the	I-OutcomeDefinition
end	I-OutcomeDefinition
of	I-OutcomeDefinition
the	I-OutcomeDefinition
antiviral	I-OutcomeDefinition
treatment	I-OutcomeDefinition
under	I-OutcomeDefinition
investigation	I-OutcomeDefinition
.	O

